(Q34977790)

5 August 2017

title

Stenotrophomonas maltophilia: an emerging opportunist human pathogen (English)

1 reference

Stenotrophomonas maltophilia

5 August 2017

main subject

1 reference

W John Looney

1

1 reference

5 August 2017

Masashi Narita

series ordinal

2

1 reference

5 August 2017

Kathrin Mühlemann

series ordinal

3

1 reference

5 August 2017

publication date

1 May 2009

1 reference

Lancet Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

9

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

312-323

1 reference

Profiling bacterial survival through a water treatment process and subsequent distribution system.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Hospital tap water as a source of stenotrophomonas maltophilia infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

BSAC standardized disc susceptibility testing method (version 7).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial therapy for Stenotrophomonas maltophilia infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Clinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia bacteremia episodes in a Turkish intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Beta-lactam resistance and beta-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Characterization of a novel T4-type Stenotrophomonas maltophilia virulent phage Smp14

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

A novel lysozyme from Xanthomonas oryzae phage varphiXo411 active against Xanthomonas and Stenotrophomonas.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Genomic diversity of the genus Stenotrophomonas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

RETRACTED: Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Evaluation of a modified selective differential medium for the isolation of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The immunomodulatory effect of antibiotics on the secretion of tumour necrosis factor alpha by peripheral blood mononuclear cells in response to Stenotrophomonas maltophilia stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Enzymatic profile of Pseudomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Early intervention and prevention of lung disease in cystic fibrosis: a European consensus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Bloodstream infection caused by Stenotrophomonas maltophilia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Bacteremia Due to Stenotrophomonas maltophilia in Patients with Hematologic Malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The clinical spectrum of stenotrophomonas (xanthomonas) maltophilia respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Quantitative cultures for diagnosing ventilator-associated pneumonia: a critique

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Fatal pulmonary hemorrhage in a patient with myelodysplastic syndrome and fulminant pneumonia caused by Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Emerging and unusual gram-negative infections in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Attributable mortality of Stenotrophomonas maltophilia bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Multiple antibiotic resistance in Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

ISCR elements: novel gene-capturing systems of the 21st century?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Heavy metal tolerance in Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Stenotrophomonas maltophilia bacteraemia in Turkish children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Trimethoprim-sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

1 reference

7 January 2021

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Optimizing therapy for Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

The efflux pump inhibitor Phe-Arg-beta-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Spread of Stenotrophomonas maltophilia colonization in a pediatric intensive care unit detected by monitoring tracheal bacterial carriage and molecular typing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970083-0

7 January 2021

10.1016/S1473-3099(09)70083-0

Identifiers

DOI

1 reference

5 August 2017

1 reference